Blueberries Medical Corp. (BBM.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 288.27 Thousand CAD | 22.44% |
| 2022 | 235.44 Thousand CAD | 69.7% |
| 2021 | 138.74 Thousand CAD | 110.29% |
| 2020 | 65.97 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 88.89 Thousand CAD | 48.99% |
| 2024 Q2 | 56.28 Thousand CAD | -36.68% |
| 2023 Q3 | 83.44 Thousand CAD | 24.06% |
| 2023 FY | 288.27 Thousand CAD | 22.44% |
| 2023 Q4 | 59.66 Thousand CAD | -28.5% |
| 2023 Q1 | 77.89 Thousand CAD | 36.53% |
| 2023 Q2 | 67.26 Thousand CAD | -13.65% |
| 2022 FY | 235.44 Thousand CAD | 69.7% |
| 2022 Q4 | 57.05 Thousand CAD | -45.59% |
| 2022 Q3 | 104.85 Thousand CAD | 163.29% |
| 2022 Q2 | 39.82 Thousand CAD | 18.13% |
| 2022 Q1 | 33.71 Thousand CAD | 195.95% |
| 2021 Q1 | 23.12 Thousand CAD | -12.33% |
| 2021 FY | 138.74 Thousand CAD | 110.29% |
| 2021 Q2 | 14.78 Thousand CAD | -36.05% |
| 2021 Q3 | 135.98 Thousand CAD | 819.72% |
| 2021 Q4 | -35.13 Thousand CAD | -125.84% |
| 2020 Q3 | 34.96 Thousand CAD | 652.86% |
| 2020 FY | 65.97 Thousand CAD | 0.0% |
| 2020 Q4 | 26.37 Thousand CAD | -24.57% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | 4644.00 CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aion Therapeutic Inc. | 367.47 Thousand CAD | 21.554% |
| Ayurcann Holdings Corp. | 25.15 Million CAD | 98.854% |
| The BC Bud Corporation | 61.48 Thousand CAD | -368.872% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | 22.559% |
| CordovaCann Corp. | 13.59 Million CAD | 97.88% |
| Christina Lake Cannabis Corp. | 11.77 Million CAD | 97.553% |
| Captor Capital Corp. | 36.76 Million CAD | 99.216% |
| City View Green Holdings Inc. | 8582.00 CAD | -3259.031% |
| 1CM Inc. | 35.34 Million CAD | 99.184% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | 94.488% |
| IM Cannabis Corp. | 48.8 Million CAD | 99.409% |
| Lobe Sciences Ltd. | 840.53 Thousand CAD | 65.704% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -380.453% |
| Nextleaf Solutions Ltd. | 8.17 Million CAD | 96.476% |
| Ovation Science Inc. | 61.93 Thousand CAD | -365.45% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -64.928% |
| RAMM Pharma Corp. | 5.06 Million CAD | 94.309% |
| RIV Capital Inc. | 7.48 Million CAD | 96.15% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 88.33 Million CAD | 99.674% |
| SLANG Worldwide Inc. | 35.68 Million CAD | 99.192% |
| 1933 Industries Inc. | 18.27 Million CAD | 98.422% |
| Red Light Holland Corp. | 4.75 Million CAD | 93.934% |
| Top Strike Resources Corp. | 13.32 Million CAD | 97.837% |
| Xebra Brands Ltd. | 106.85 Thousand CAD | -169.779% |
| Adastra Holdings Ltd. | 22.22 Million CAD | 98.703% |